Cargando…
Statin Use Is Associated with Reduced Risk of Haematological Malignancies: Evidence from a Meta-Analysis
BACKGROUND: Several observational studies have shown that statin use may modify the risk of haematological malignancies. To quantify the association between statin use and risk for haematological malignancies, we performed a detailed meta-analysis of published studies regarding this subject. METHODS...
Autores principales: | Yi, Xiao, Jia, Wei, Jin, Yin, Zhen, Shang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909054/ https://www.ncbi.nlm.nih.gov/pubmed/24498014 http://dx.doi.org/10.1371/journal.pone.0087019 |
Ejemplares similares
-
Incidence and Risk of Cardiotoxicity Associated with Bortezomib in the Treatment of Cancer: A Systematic Review and Meta-Analysis
por: Xiao, Yi, et al.
Publicado: (2014) -
Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013) -
Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies
por: Mynott, Rachel L., et al.
Publicado: (2023) -
Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014) -
PSYCHOLOGICAL ASPECTS OF HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, P., et al.
Publicado: (1990)